Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-01-25 @ 12:16 AM
Study NCT ID:
NCT05618366
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2022-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Sponsor:
Weill Medical College of Cornell University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
22-04024678
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None